Aliyah Baluch, MD, Msc
Friday, October 19, 2018
Category: Immunocompromised Host, Mould Infections, Transplant Infectious Diseases

Dr. Baluch reviews the topic of invasive fungal infections (IFIs) in individuals who undergo hematopoietic stem cell transplantation (HCST). The author begins by reviewing risk factors for IFIs. She then discusses what constitutes an IFI. She differentiates infections caused by yeasts versus those due to molds, and discusses the assessment and management of invasive candida disease. Next, Dr. Baluch discusses non candida molds, including aspergillus, fusarium, and Mucor as well as atypical pathogens such as Pneumocystis. She closes with a discussion of antifungal therapy and what constitutes the ideal fungal agent.

Stay in touch! Download our app in the iTunes store or the Google Marketplace.